In order to determine if the observed reduced tumor volume in the Cal+Cur group was related to differences in the intratumor vessel network, microvessel count was performed using the integrin subunit β (Itgb3) as a marker of activated endothelium. The gene discussed is ITGB3; the disease is neoplasm.